Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
25.08
-0.61 (-2.37%)
Nov 17, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 10.17 billion as of November 16, 2026. It is the 7,612th most valuable company in the world and the 1,464th biggest in China. Its market cap has increased by 0.96% in one year.
Market Cap
10.17B
Enterprise Value
10.52B
Revenue
796.18M
Global Rank
Country Rank
#1,464 China
PE Ratio
n/a
ChartMarket Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 10.17B, a decrease of -37.12%. That is a compound annual growth rate of -8.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 10.17B | -1.23% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 12.75B |
| BrightGene Bio-Medical Technology | 12.14B |
| Sino Biological,Inc. | 11.18B |
| Inner Mongolia Furui Medical Science | 11.04B |
| Nanjing Vazyme Biotech | 10.69B |
| Tibet Cheezheng Tibetan Medicine | 10.59B |
| Shanghai Medicilon | 9.76B |
| Shanghai OPM Biosciences | 8.99B |